A phase I/II randomized, observer-blind, controlled study to assess safety and immunogenicity of acellular Pertussis vaccine given alone or in combination with Tetanus-diphtheria vaccine in healthy adults aged 18-35 years

Trial Profile

A phase I/II randomized, observer-blind, controlled study to assess safety and immunogenicity of acellular Pertussis vaccine given alone or in combination with Tetanus-diphtheria vaccine in healthy adults aged 18-35 years

Completed
Phase of Trial: Phase I/II

Latest Information Update: 15 Dec 2017

At a glance

  • Drugs Pertussis acellular vaccine (Primary)
  • Indications Pertussis
  • Focus Adverse reactions
  • Sponsors BioNet-Asia
  • Most Recent Events

    • 28 Nov 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top